Expression of CDK6 in nasopharyngeal carcinoma and its clinical significance
10.3969/j.issn.1673-4254.2013.12.22
- VernacularTitle:CDK6在鼻咽癌中的表达及临床意义
- Author:
Xiaopeng LUO
1
;
Jixin QIN
;
Yongzhi HUANG
;
Jin LIU
;
Ying WANG
;
Huaifei WANG
;
Jiajun CHEN
Author Information
1. 广西右江民族医学院附属医院耳鼻喉科
- Keywords:
nasopharyngeal carcinoma;
CDK6;
immunohistochemistry
- From:
Journal of Southern Medical University
2013;(12):1811-1814
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression of CDK6 in nasopharyngeal carcinoma (NPC) and explore its clinical significance. Methods Immunohistochemistry was used to examine the differential expression of CDK6 protein in 101 NPC and 30 nasopharyngeal tissues, and the correlation of CDK6 expression with the clinical characteristics was analyzed in NPC cases. Results Immunohistochemistry demonstrated that CDK6 protein was a co-expressed factor in the cytoplasm and cell nuclei. CDK6 was expressed predominantly in the cytoplasm in nasopharyngeal tissues, but in NPC tissues, CDK6 was co-expressed predominantly in the cytoplasm and nuclei. Compared to the nasopharyngeal tissues, NPC tissues showed significantly up-regulated CDK6 expression (P=0.009) in positive correlation with tumor size (P=0.020) and clinical stages (P=0.0039). Conclusion Increased CDK6 protein expression is an unfavorable factor that promotes the development and progression of NPC.
